Literature DB >> 2358780

Parallel evolution of antibody variable regions by somatic processes: consecutive shared somatic alterations in VH genes expressed by independently generated hybridomas apparently acquired by point mutation and selection rather than by gene conversion.

L J Wysocki1, M L Gefter, M N Margolies.   

Abstract

We identified, in independently generated hybridoma antibodies, blocks of shared somatic alterations comprising four consecutive amino acid replacements in the CDR2s of their heavy chain variable regions. We found that the nucleotide sequences encoding the shared replacements differed slightly. In addition, we performed genomic cloning and sequencing analyses that indicate that no genomic sequence could encode the block of shared replacements in any one of the antibodies and thus directly serve as a donor by a recombinational process. Finally, in a survey of other somatically mutated versions of the same heavy chain variable gene, we found several examples containing one, two, or three of the shared CDR2 mutations in various combinations. We conclude that the shared somatic alterations were acquired by several independent events. This result, and the fact that the antibodies containing the four shared mutations were elicited in response to the same antigen and are encoded by the same VH and VK gene segments, suggests that an intense selection pressure has fixed the shared replacements by favoring the clonal expansion of B cells producing antibodies that contain them. The basis of this selection pressure is addressed elsewhere (Parhami-Seren, B., L. J. Wysocki, M. N. Margolies, and J. Sharon, manuscript submitted for publication).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358780      PMCID: PMC2188175          DOI: 10.1084/jem.172.1.315

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  56 in total

1.  Mitogen-driven B cell proliferation and differentiation are not accompanied by hypermutation of immunoglobulin variable region genes.

Authors:  T Manser
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

2.  The role of clonal selection and somatic mutation in autoimmunity.

Authors:  M J Shlomchik; A Marshak-Rothstein; C B Wolfowicz; T L Rothstein; M G Weigert
Journal:  Nature       Date:  1987 Aug 27-Sep 2       Impact factor: 49.962

3.  Complete heavy and light chain variable region sequence of anti-arsonate monoclonal antibodies from BALB/c and A/J mice sharing the 36-60 idiotype are highly homologous.

Authors:  E Juszczak; R I Near; M L Gefter; M N Margolies
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

4.  Use of o-phthalaldehyde to reduce background during automated Edman degradation.

Authors:  A W Brauer; C L Oman; M N Margolies
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

5.  Somatic diversification of immunoglobulins.

Authors:  S Rudikoff; M Pawlita; J Pumphrey; M Heller
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Complete amino acid sequence of the heavy-chain variable region from an A/J mouse antigen-nonbinding monoclonal antibody bearing the predominant arsonate idiotype.

Authors:  J A Smith; M N Margolies
Journal:  Biochemistry       Date:  1984-09-25       Impact factor: 3.162

7.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin.

Authors:  D McKean; K Huppi; M Bell; L Staudt; W Gerhard; M Weigert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

8.  Immunoglobulin V region variants in hybridoma cells. II. Recombination between V genes.

Authors:  R Dildrop; M Brüggemann; A Radbruch; K Rajewsky; K Beyreuther
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

9.  Single germline VH and V kappa genes encode predominating antibody variable regions elicited in strain A mice by immunization with p-azophenylarsonate.

Authors:  L J Wysocki; T Gridley; S Huang; A G Grandea; M L Gefter
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

10.  Evolution of antibody structure during the immune response. The differentiative potential of a single B lymphocyte.

Authors:  T Manser
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  7 in total

1.  B-cell proliferation initiated by Ia cross-linking and sustained by interleukins leads to class switching but not somatic mutation in vitro.

Authors:  L J Wysocki; G Creadon; K R Lehmann; J C Cambier
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

2.  Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene.

Authors:  S G Lebecque; P J Gearhart
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

3.  Aborted germinal center reactions and B cell memory by follicular T cells specific for a B cell receptor V region peptide.

Authors:  Ryan A Heiser; Christopher M Snyder; James St Clair; Lawrence J Wysocki
Journal:  J Immunol       Date:  2011-05-27       Impact factor: 5.422

4.  Germ line variable regions that match hypermutated sequences in genes encoding murine anti-hapten antibodies.

Authors:  V David; N L Folk; N Maizels
Journal:  Genetics       Date:  1992-11       Impact factor: 4.562

5.  Gene Conversion-Like Events in the Diversification of Human Rearranged IGHV3-23*01 Gene Sequences.

Authors:  Bhargavi Duvvuri; Gillian E Wu
Journal:  Front Immunol       Date:  2012-06-15       Impact factor: 7.561

6.  Different epitope structures select distinct mutant forms of an antibody variable region for expression during the immune response.

Authors:  S Fish; M Fleming; J Sharon; T Manser
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

7.  Molecular evolution of the human immunoglobulin E response: high incidence of shared mutations and clonal relatedness among epsilon VH5 transcripts from three unrelated patients with atopic dermatitis.

Authors:  N van der Stoep; J van der Linden; T Logtenberg
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.